4 completed, 4 unknown, 2 terminated, 2 withdrawn. 4 Not applicable, 3 Phase 2, 2 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Terminated 2, Completed 1, Withdrawn 1 |
| Phase 2 | 3 | Unknown 2, Completed 1 |
| Phase 4 | 2 | Recruiting 1, Withdrawn 1 |
| Phase 1 | 1 | Unknown 1 |
Follow this condition Literature Review of Skin Graft Complications trials Research Report on Skin Graft Complications
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess the Safety and Efficacy of DERMASEAL for the Treatment of Split-Thickness Skin Graft Donor Site Wounds DERMASEAL - Skin Graft Complications | Phase 1 / Phase 2 | Unknown | Hobart W. Harris | 12 | 2024-09-01 | 2024-06-11 |
| Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft Tranexamic acid, Thrombin JMI, skin graft - Burns, Skin Graft Complications | Phase 4 | Recruiting | University of Kansas Medical Center | 62 | 2024-07-11 | 2026-08-27 |
| The Rule of Bupivacaine Hydrochloride in Skin Graft Donor Site Bupivacain - Skin Graft Complications, Pain Management | Phase 2 | Completed | Minia University | 90 | 2023-03-01 | 2025-01-13 |
| The Contributions of the Multidisciplinary Management of Prosthesis Knee Infections in a Reference Center: A Retrospective Study About 52 Cases.Skin Coverage in a Reference Center: A Retrospective Study About 52 Cases patients having had skin coverage of the knee - Knee Joint Prosthesis Infection, Flap Necrosis | Unknown | Hospices Civils de Lyon | 52 | 2022-05-01 | 2022-05-10 | |
| Effectiveness and Tolerability of Fitostimoline Plus vs Connettivina Bio Plus in Skin Graft Fitostimoline plus, Connettivina bio plus - Wounds and Injuries, Skin Graft Scar | Unknown | Federico II University | 60 | 2021-01-18 | 2022-07-07 | |
| Factors Affecting Split Thickness Skin Graft Success Rates in Patients Who Underwent a Radial Forearm or Fibula Free Flap Cast and bolster placement duration, Standard of care - Skin Graft Complications | Not applicable | Completed | University of Southern California | 75 | 2021-01-05 | 2026-02-10 |
| Clinical Safety and Scar Prevention Study of a Topical Antifibrotic Compound FS2. Fibrosis-Inhibiting-Compound-FS2, Vehicle moisture balancing base - Scar, Cicatrix | Phase 2 | Unknown | University of British Columbia | 50 | 2019-12-05 | 2019-12-17 |
| The Effect of Platelet Rich Plasma on Pain at Skin Graft Donor Sites PRP harvest and preparation - Skin Graft (Allograft) Rejection, Skin Graft Complications | Not applicable | Terminated | University of Arizona | 25 | 2019-11-01 | 2024-03-22 |
| Suprathel Versus Xeroform for the Management of Skin Graft Donor Sites Suprathel or Xeroform donor site application - Burns, Skin Graft Complications | Not applicable | Terminated | University of Colorado, Denver | 10 | 2019-07-07 | 2020-10-22 |
| Efficacy and Safety of a Nanofat-seeded Biological Scaffold in Healing Lower Limb Surgical Defects Nanofat-seeded biological scaffold on surgical defect - Wound of Skin, Non-melanoma Skin Cancer | Not applicable | Withdrawn | Brigham and Women's Hospital | 2019-01-30 | 2020-02-11 | |
| A Comparison of OASIS Wound Matrix With Approved Dressings for Skin Graft Donor Sites Tegaderm™(Absorbant, 3M), OASIS® wound matrix, Xeroform™ - Skin Graft Complications | Phase 4 | Withdrawn | Loma Linda University | 2016-10-01 | 2016-12-16 | |
| Antithrombotics and Complications in Skin Grafts Skin Graft Complications | Completed | Aalborg University Hospital | 172 | 2015-01-01 | 2020-01-18 | |
| Retrospective Analysis of Spray Skin Treats for Severe Burns spray skin, Control group - Morality, Skin Graft Complications | Completed | First Affiliated Hospital, Sun Yat-Sen University | 85 | 2012-01-01 | 2023-12-14 |
Burns (3) · Cicatrix (2) · Pain (2) · Agnosia (1) · Cicatrix, Hypertrophic (1) · Keloid (1) · Rejection, Psychology (1) · Skin Abnormalities (1) · Wounds and Injuries (1)
Pathological Conditions, Signs and Symptoms (3) · Wounds and Injuries (3) · Fibrosis (2) · Neurologic Manifestations (2) · Pathologic Processes (2) · Signs and Symptoms (2) · Skin and Connective Tissue Diseases (2) · Behavior (1) · Collagen Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Connective Tissue Diseases (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Perceptual Disorders (1)
2,4,6-tribromophenol (1) · Bupivacaine (1) · Control Groups (1) · POLR1G protein, human (1) · Skin Transplantation (1) · Standard of Care (1) · Thrombin (1) · Tranexamic Acid (1) · Transplantation, Autologous (1) · poly(lactide-co-trimethylenecarbonate-co-epsilon-caprolactone) (1)
Aalborg University Hospital (1) · Brigham and Women's Hospital (1) · Federico II University (1) · First Affiliated Hospital, Sun Yat-Sen University (1) · Hobart W. Harris (1) · Hospices Civils de Lyon (1) · Loma Linda University (1) · Minia University (1) · University of Arizona (1) · University of British Columbia (1) · University of Colorado, Denver (1) · University of Kansas Medical Center (1) · University of Southern California (1)
United States (5) · Canada (1) · China (1) · Denmark (1) · Egypt (1) · France (1) · Italy (1)
Aditya Manoharan, MD (1) · Anthony Papp, MD, PhD (1) · Chrysalyne D Schmults, MD, MSCE (1) · David M Young, MD (1) · Dhaval Bhavsar, MBBS (1) · Hahns Kim, MD (1) · Jason Lowe, MD (1) · Jiayuan Zhu (1) · Mohab Elsayed, Phd (1) · Shadwa Rabea, MD (1) · Steven Moulton, MD (1) · Subhas Gupta, MD, PhD (1)
PMID 15886669, PMID 18467932, PMID 21999705, PMID 22011820, PMID 22028946, PMID 22179187, PMID 22663170, PMID 25623477, PMID 30211382